Lilly CEO Lechleiter Criticizes Obama's Plans to Close Corporate Tax Loopholes

A Stronger FDA: PhRMA's and Angell's Prescriptions

Former Pfizer R&D Chief John LaMattina Dispels Some Pharma Myths, Perpetuates Others

Genchi Genbutsu: Lilly’s Lechleiter Visits the Night Shift

Pfizer-Wyeth: The Blockbuster Model's Latest Monster?

Can Academia Save Pharma? U Mich to Take Over Pfizer Site